Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Information
Welcome
Investor Fact Sheet
Investor Presentations
Media
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements & Reports
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
Contact Us
Contact Us
Email Alerts
Announcements & Reports
Announcements & Reports
>
ASX Announcements
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
19 Apr 2023
First Patient Recruited to Cohort 3 of ACCENT Trial
11 Apr 2023
Dose Escalation Approved in ACCENT Clinical Trial of AMP945
28 Feb 2023
ACCENT Trial Recruitment Progress
23 Feb 2023
ATX - US Conference Presentation
09 Feb 2023
AmpliaTherapeutics - Lorne Cancer Conference Presentation
01 Feb 2023
First Patient Recruited to Cohort 2 of Accent Trial
30 Jan 2023
Quarterly Activities and Cashflow Reports - December 2022
11 Jan 2023
Dose Escalation Approved in ACCENT Clinical Trial of AMP945
Previous
1
2
3
4